scispace - formally typeset
E

Erin P. Keaney

Researcher at Novartis

Publications -  10
Citations -  825

Erin P. Keaney is an academic researcher from Novartis. The author has contributed to research in topics: Autophagy & PI3K/AKT/mTOR pathway. The author has an hindex of 8, co-authored 9 publications receiving 625 citations.

Papers
More filters
Journal ArticleDOI

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors

TL;DR: It is presented that while HCQ is ineffective, Lys05-mediated autophagy inhibition reduces LSCs quiescence and drives myeloid cell expansion, providing a strong rationale for clinical use of second generation autophagic inhibitors as a novel treatment for CML patients with LSC persistence.